Investor directory

DW Healthcare Partners

DW Healthcare Partners is a private equity firm established in 2002 and based in Toronto, Canada, specializing exclusively in the healthcare sector. The firm focuses on acquiring majority interests in mid-stage healthcare companies through buyouts, management buyouts, and growth equity investments. With over $1.43 billion in aggregate capital commitments, DW Healthcare Partners emphasizes investing in companies with proven management teams and offers not just financial backing but also strategic guidance and acquisition expertise to help these companies achieve their growth potential. The firm predominantly targets businesses within the healthcare and healthcare services sector in North America.
http://dwhp.com
https://crunchbase.com/organization/dw-healthcare-partners
https://linkedin.com/company/dw-healthcare-partners
https://pitchbook.com/profiles/investor/10071-64
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=1826397
https://www.privateequityinternational.com/database/#/profile?id=7014

Becher, Gabriel

Managing Director

Andrew Carragher

Founder, Managing Director

Aly Champsi

Managing Director and Partner

Mo Gulamhusein

Vice President

Alexandra Karacsony

Director, Investment Sourcing

Trevor Matthews

Vice President

Eric Moore

Principal

Past deals in Utah

Go-2 Fulfillment

Acquisition in 2019
Go-2 Fulfillment is a top to bottom solution to your packaging and shipping needs.

Tandem Labs

Series A in 2005
Tandem Labs is a bioanalytical contract research organization based in Salt Lake City, Utah, that supports pharmaceutical and biotechnology companies in their clinical and preclinical drug development programs. Founded in 1995, Tandem Labs specializes in mass spectrometry and immunochemistry services, offering a range of bioanalytical studies. The company develops, validates, and performs spectrometry-based methods in compliance with Good Laboratory Practice (GLP) standards, providing services such as method development and validation, dose formulation analysis, and clinical sample analysis. Additionally, Tandem Labs delivers immunoanalytical services and biomarker services, catering to both GLP and non-GLP discovery needs. The organization was acquired by LabCorp in January 2008, further enhancing its capabilities in drug development support.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.